**Question:** The 23 valent pneumococcal vaccine is recommended in all except - A. children <2 years old; B. pregnant women; C. individuals with severe combined immunodeficiency disease (SCID); D. persons with a history of severe allergic reactions to the vaccine or its components. **Core Concept:** The 23-valent pneumococcal polysaccharide vaccine (PPV23) is a vaccine used to prevent pneumococcal infections caused by Streptococcus pneumoniae, a common bacterium that can cause pneumonia, meningitis, and other life-threatening diseases. **Correct Answer: .** **Why the Correct Answer is Right:** Option A (children <2 years old): Infants aged less than two years are immunologically immature, which makes them more susceptible to infections. PPV23 would not provide optimal protection in this age group. Option B (pregnant women): Immunizations during pregnancy should be administered with caution, as PPV23 might cross the placenta and interfere with fetal immune development. Option C (individuals with severe combined immunodeficiency disease (SCID)): SCID is a severe type of immunodeficiency disorder where the immune system is severely compromised. PPV23 cannot provide significant protection to these patients. Option D (persons with a history of severe allergic reactions to the vaccine or its components): Patients with a history of severe allergic reactions should avoid PPV23 to prevent potential adverse reactions. **Why Each Wrong Option is Incorrect:** Option A (children <2 years old): Immunizations should be administered based on the individual's age, developmental stage, and overall health status. In infants aged less than two years, PPV23 might not provide optimal protection, as their immune system is still developing. Option B (pregnant women): Immunizations during pregnancy require careful consideration due to potential adverse effects on the fetus. PPV23 might cross the placenta and interfere with fetal immune development. Option C (individuals with severe combined immunodeficiency disease (SCID)): SCID patients have a severely compromised immune system, rendering them unable to mount an effective immune response to PPV23. Option D (persons with a history of severe allergic reactions to the vaccine or its components): Patients with a history of severe allergic reactions pose a risk for potential adverse reactions when receiving PPV23, as they have a predisposition to severe allergic reactions. **Clinical Pearl:** When prescribing immunizations, it is essential to consider the individual's age, immunological status, and potential adverse effects on the fetus or the immune system. In the case of severe immunodeficiency disorders or severe allergic reactions, it is safer to avoid administering PPV23 to prevent complications or exacerbating the patient's condition.